Trials / Completed
CompletedNCT00193167
Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer
Phase II Study of Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- SCRI Development Innovations, LLC · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This non-randomized phase II study is designed to assess the response rate and toxicity of weekly topotecan as second-line treatment in patients with relapsed or refractory metastatic colorectal cancer.
Detailed description
Upon determination of eligibility, patients will be receive: * Topotecan
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topotecan |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2006-04-01
- Completion
- 2006-04-01
- First posted
- 2005-09-19
- Last updated
- 2011-05-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00193167. Inclusion in this directory is not an endorsement.